Benzinga | Oct 26, 2020 06:48AM EDT

SVB Leerink Assumes Axcella Health at Outperform, Announces Price Target of $10

SVB Leerink analyst Thomas Smith assumes Axcella Health (NASDAQ:AXLA) with a Outperform rating and announces Price Target of $10.